IGF1 and cancer: In fact, IGF-I signaling is also relevant to neoplasia in a number of other tissues such as peripheral nervous system, skin, and prostate [34-38], and epidemiological studies have linked high circulating levels of IGF-I with increased cancer risk in breast, prostate and colon cancer [39-44].